SCHEMBL5330841

SCHEMBL5330841

O=C(O)C1NCC(NOCc2ccccc2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
EPHX2 P34913 2/20 0.38
MC4R P32245 2/20 0.36
HTR2C P28335 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
NAAA Q02083 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
HTR1A P08908 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5187221 0.89 NPC1 (0.37) TSHRNPSR1NPC1RAB9AEPHX2
SCHEMBL4694770 0.84 NPC1 (0.35) NPC1RAB9AEPHX2MC4RHTR2C
SCHEMBL4696597 0.83 NPC1 (0.35) NPC1RAB9AEPHX2MC4RHTR2C
SCHEMBL5256975 0.82 NAAA (0.52) TSHRALDH1A1GAANAAA
SCHEMBL5256420 0.81 BCHE (0.42) NPC1RAB9AALDH1A1GAAMAPKAPK2
SCHEMBL4136367 0.81 BCHE (0.42) NPC1RAB9AALDH1A1GAAMAPKAPK2
SCHEMBL5255876 0.80 MEN1 (0.37) NPC1RAB9AALDH1A1GAAHTR1A
SCHEMBL4693843 0.79 KEAP1 (0.40) TSHRNPC1RAB9AALDH1A1
SCHEMBL4155681 0.77 ALDH1A1 (0.34) TSHRNPSR1NPC1RAB9AEPHX2
SCHEMBL4695715 0.77 NPC1 (0.33) NPSR1NPC1RAB9AEPHX2MC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed